The activation of this signaling pathway progressively increased in different types of gliomas, with the highest activity seen in patients with glioblastoma, a particularly difficult - to -
treat form of brain cancer that represents approximately 15 percent of all brain tumors.
Not exact matches
Dr Iain Foulkes, director
of research and innovation at
Cancer Research UK, said: «We urgently need new insights and treatments to tackle glioblastomas, one
of the most common and difficult to
treat forms of brain tumours.
This approach has been investigated by TransMolecular, a company based in Cambridge, Massachusetts, as a way to
treat glioma, a
form of brain cancer.
Dr. Max Schwarz, an oncologist and clinical professor at Monash University in Melbourne, Australia,
treated some
brain -
cancer patients with the experimental injectable
form of Temodar and others with the capsule formulation.
A molecule in cells that shuts down the expression
of genes might be a promising target for new drugs designed to
treat the most frequent and lethal
form of brain cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — J
cancer, according to a new study by researchers at The Ohio State University Comprehensive
Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — J
Cancer Center — Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — J
Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
NEW YORK — In 30 years as an oncologist, Dr. Howard Fine estimates he has
treated some 20,000 patients with glioblastomas, the most deadly
form of brain cancer, «and almost all
of them are dead.»
Proton beam therapy — a more precise
form of radiotherapy — to
treat the childhood
brain cancer medulloblastoma appears to be as safe as conventional radiotherapy with similar survival rates, according to new research published in The Lancet Oncology journal.
An international team
of researchers has found a drug previously approved to
treat breast
cancer could also be used to shrink medulloblastoma, a common
form of childhood
brain tumour.